lpca Laboratories inks tech transfer deal with Omexa Formulary
lpca to grant Omexa non-exclusive right to develop, manufacture, and globally market anti-cancer biosimilar
lpca to grant Omexa non-exclusive right to develop, manufacture, and globally market anti-cancer biosimilar